JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Prognostic value of inflammatory markers for mortality in hemodialysis patients: a retrospective study with over 3-year follow-up
Abstract
Aims: In chronic kidney disease (CKD), chronic systemic inflammation contributes to premature ageing and morbidity; it is a predictor of overall mortality. In this study, we aimed to investigate prognostic value of inflamatory markers including systemic immune-inflammation index (SII), pan-immune-inflammation value (PIV), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for mortality outcomes in hemodialysis patients.
Methods: In this retrospective study, CKD patients on maintenance hemodialysis between January 1, 2020 and January 31, 2020 were included. SII, PIV, NLR, PLR values of the patients were calculated. SII was calculated by (neutrophil count x platelet count)/lymphocyte count; PIV was calculated by (neutrophil count x platelet count x monocyte count)/lymphocyte count. Mortality rate of the study population during approximately 38-month follow-up period was calculated. The relationships of inflamatory markers and other variables with mortality were analysed.
Results: Of 162 patients, 53.1% were male and 46.9% were female (mean age: 61.6±13.5). During 38-month follow-up period, a total of 60 patients (37%) died. Compared with surviving group, NLR values, mean age and the rate of diabetes mellitus (DM) and coronary artery disease (CAD) comorbidities were higher (p=0.012, p<0.001, p=0.008, p<0.001 respectively) and albumin, uric acid and creatinin levels were lower (p <0.001, for each) in the nonsurvivor group. There was no difference between these two groups in terms of PIV and SII values and CRP levels. In Cox regression analysis, presence of CAD (Exp ß: 2.116; 95% CI, 1.222-3.648; p=0.007), age (Exp ß: 1.049; 95% CI, 1.022-1.077; p <0.001), serum uric acid (Exp ß: 0.721; 95% CI, 0.559-0.929; p=0.011) and albumin levels (Exp ß: 0.395;95% CI, 0.158-0.984, p=0.046), NLR (Exp ß: 1.345; 95% CI, 1.152-1.1570; p<0.001) and PLR (Exp ß: 0.993; 95% CI, 0.989-0.997; p=0.002) were found to be associated with mortality.
Conclusion: There was no difference between nonsurviving and surviving group in terms of PIV and SII values and CRP levels. Age, presence of CAD, serum uric acid and albumin levels and NLR and PLR values were associated with all-cause mortality, independently. Prospective studies with larger number of hemodialysis patients and serial measurements of inflammatory markers are needed.

Keywords : Hemodialysis, systemic immune-inflammation index, pan-immune-inflammation value, mortality, inflammatory markers

Download Article


1. Saran R, Robinson B, Abbott KC, et al. US Renal Data System2019 Annual Data Report: epidemiology of kidney disease in theUnited States. Am J Kidney Dis. 2020;75(1 Suppl 1):A6-A7.
2. Alanlı R, K&uuml;&ccedil;&uuml;kay MB, M&uuml;rsel Ş, et al. Hemodiyaliz hastalarındamortaliteye etkisi olan kan parametreleri ve ekokardiyografi bulguları. Ankara Eğ Araşt Hast Tıp Derg. 2022; 55(2):74-77.
3. Henrich WL, Burkart JM.Patient survival and maintenancedialysis. UpToDate. Updated October 05, 2020. Accessed May 10,2023. http://www.uptodate.com
4. Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation inend-stage renal disease and dialysis. Nephrol Dial Transplant.2018;33(suppl_3):iii35-iii40.
5. Kato A, Tsuji T, Sakao Y, et al. A comparison of systemicinflammation-based prognostic scores in patients on regularhemodialysis. Nephron Extra. 2013;3(1):91-100.
6. Liao J, Wei D, Sun C, Yang Y, Wei Y, Liu X. Prognostic value of thecombination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortalityin patients on maintenance hemodialysis. BMC Nephrol.2022;23(1):393.
7. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammationindex predicts prognosis of patients after curative resection forhepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222.
8. Zhong JH, Huang DH, Chen ZY. Prognostic role of systemicimmune-inflammation index in solid tumors: A systematic reviewand meta-analysis. Oncotarget. 2017;8(43):75381-75388.
9. Tutan D, Eskin F. Role of systemic immune-inflammation indexin predicting mortality in cancer patients in palliative care units. JHealth Sci Med. 2023;6(2):223-227.
10. Zhang F, Li L, Wu X, et al. Pan-immune-inflammation value isassociated with poor prognosis in patients undergoing peritonealdialysis. Ren Fail. 2023;45(1):2158103.
11. Sevinc C, Demirci R, Timur O. Predicting hospital mortality inCOVID-19 hemodialysis patients with developed scores. SeminDial. 2021;34(5):347-359.
12. Ran Y, Wu QN, Long YJ, et al. Association of systemic immune-inflammation index with protein-energy wasting and prognosisin patients on maintenance hemodialysis. Zhonghua Yi Xue ZaZhi. 2021;101(28):2223-2227.
13. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present andfuture perspectives. Bratisl Lek Listy. 2021;122(7):474-488.
14. Yousif DE, Ye X, Stuard S, et al. Biphasic dynamics of inflammatorymarkers following hemodialysis initiation: results from theInternational MONitoring Dialysis Outcome Initiative. KidneyInt Rep. 2022;8(1):75-80.
15. Oguz EG, Yeter HH, Akcay OF, et al. Predictive value of neutrophil-to-lymphocyte ratio in terms of need for intensive care unit andmortality in maintenance hemodialysis patients with COVID-19.Hemodial Int. 2022;26(3): 377-385.
16. Li M, Ye ZC, Li CM, et al. Low serum uric acid levels increase therisk of all-cause death and cardiovascular death in hemodialysispatients. Ren Fail. 2020;42(1):315-322.
17. Murea M, Tucker BM. The physiology of uric acid and theimpact of end-stage kidney disease and dialysis. Semin Dial.2019;32(1):47-57.
18. Kazan DE, Kazan S. Systemic immune inflammation indexand pan-immune inflammation value as prognostic markers inpatients with idiopathic low and moderate risk membranousnephropathy. Eur Rev Med Pharmacol Sci. 2023;27(2): 642-648.
Article available in :
Volume 6, Issue 5, 2023
Page : 1010-1015
https://doi.org/10.32322/jhsm.1311565
Article Information
Received : 08 Haz 2023
Accepted : 03 Eyl 2023
Published : 28 Eyl 2023
Corresponding Author :

Raziye Yazıcı: Department of Nephrology, Konya Beyhekim Training and Research Hospital, Konya, Turkey

[email protected]
Citation : Yazıcı R, Güney İ. Prognostic value of inflammatory markers for mortality in hemodialysis patients: a retrospective study with over 3-year follow-up. J Health Sci Med. 2023;6(5):1010-1015.

Read: 250
Cited: 0
Download : 328
_Footer